Phage-Mimetic Nanorods for Targeted Breast Cancer Treatment
用于靶向乳腺癌治疗的噬菌体模拟纳米棒
基本信息
- 批准号:7904784
- 负责人:
- 金额:$ 21.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-01 至 2012-08-31
- 项目状态:已结题
- 来源:
- 关键词:AblationAffinityAftercareAmino AcidsAnimal ModelAnimalsAntineoplastic AgentsAutomobile DrivingBacteriaBacteriophagesBindingBiocompatibleBiologicalBiomimeticsBrainBreastBreast Cancer CellBreast Cancer TreatmentC-terminalCapsid ProteinsCarbonCellsChemicalsDNADataDiseaseDistalElectrostaticsEngineeringEnvironmentFigs - dietaryGeneticGoalsGoldHandHeartHeatingHistologicHome environmentHomingHydrophobic InteractionsImageImmune responseLengthLibrariesLightMalignant NeoplasmsMammalian CellMammary NeoplasmsMinorMonitorMusN-terminalNanotechnologyOrganOutcomePeptidesPhage DisplayPhosphate BufferProcessProteinsRandom Peptide LibrariesRestSalineSideSilver StainingSilver stain methodSpecificityStructureSurfaceSurvival AnalysisTechnologyTemperatureTestingTetanus Helper PeptideTherapeuticTherapeutic AgentsTimeTissuesToxic effectTumor TissueVirusbasecancer cellcancer therapydesigndriving forcein vivoinnovationirradiationkillingsmalignant breast neoplasmmimeticsnanonanomaterialsnanomedicinenanoparticlenanorodnanoscalenovelnovel strategiesnovel therapeuticsparticlephysical propertypublic health relevanceresearch studyresponseretinal rodsself assemblytreatment strategytumor
项目摘要
DESCRIPTION (provided by applicant): In vivo phage display can identify tumor-homing proteins that are specific to the vasculature of a specific tumor tissue and the tumor vasculature is a suitable target for cancer therapy. However, such tumor-homing proteins cannot destruct tumors directly without being conjugated with anti-cancer agents. On the other hand, nanomaterials such as gold nanorods (AuNRs) can rapidly convert tissue-penetrating near infrared (NIR) irradiation into heat to raise the local temperature and thermally destruct tumors. However, AuNRs lack biological recognitions that can allow them to target and attack tumors specifically. This project is innovative because it integrates the tumor-homing proteins established by in vivo phage display and tumor-destructing AuNRs. The objectives of this application are (1) to mimic how proteins and DNA are assembled into a nanorod-like phage particle to assemble target-specific phage coat proteins and a DNA-immobilized AuNR into a phage-mimetic nanorod (PMNR) which can serve as a nano-tumor-heater and (2) to impart the breast tumor-homing specificity to the PMNR through genetically identifying tumor-homing phage coat proteins by using in vivo major coat phage display technology. The overall hypotheses of this project are that (1) major coat protein (pVIII) of nanorod-like fd-tet phage, which is genetically engineered to home to breast tumor through major coat phage display technology, can biomimetically self-assemble on the DNA-immobilized gold nanorods (AuNRs) with tumor-homing peptide motif protruding from the surface and (2) the resultant multi-functional PMNR will serve as a breast tumor-targeting nano-heater to selectively destruct breast tumor upon NIR irradiation. Three specific aims are designed to test our central hypotheses: Aim 1: Identify tumor-homing peptides that are fused to pVIII of nanorod-like phage from a phage-displayed random peptide library. Aim 2: Establish the biomimetic assembly of tumor-homing phage proteins on the DNA-immobilized AuNRs to form tumor-homing PMNRs by mimicking how pVIII is assembled along DNA during natural phage assembly. Aim 3: Test the targeted photothermal ablation of breast tumors using the tumor-targeting PMNRs. This project will result in a new tumor-homing anti-cancer agent and a novel strategy for targeted breast cancer therapy. It will also generate a novel biomimetic strategy for imparting biological recognitions to nanomaterials in nanomedicine.
PUBLIC HEALTH RELEVANCE: Phage-mimetic nanorods for targeted breast cancer treatment Project Narrative This project will use a biomimetic strategy to bring together tumor-homing proteins and tumor-destructing nanomaterials to develop a new anti-cancer agent. The new therapeutic agent can recognize breast tumors and destruct the tumors in response to a tissue-penetrating light. It will result in a novel nanotechnological strategy for targeted breast cancer therapy.
描述(由申请人提供):体内噬菌体展示可以识别特定肿瘤组织的脉管系统特异性肿瘤归巢蛋白,肿瘤脉管系统是癌症治疗的合适靶点。然而,如果不与抗癌药物结合,这种肿瘤归巢蛋白不能直接破坏肿瘤。另一方面,像金纳米棒(aunr)这样的纳米材料可以将穿透组织的近红外(NIR)辐射迅速转化为热量,从而提高局部温度并热破坏肿瘤。然而,aunr缺乏能够使它们特异性靶向和攻击肿瘤的生物学识别。该项目的创新之处在于,它将体内噬菌体展示建立的肿瘤归巢蛋白和肿瘤破坏aunr结合在一起。本应用程序的目的是:(1)模拟蛋白质和DNA如何组装成纳米棒状噬菌体颗粒,将靶向噬菌体外壳蛋白和DNA固定的AuNR组装成可作为纳米肿瘤加热器的噬菌体模拟纳米棒(PMNR);(2)通过使用体内主要外壳噬菌体展示技术,通过基因鉴定肿瘤归巢噬菌体外壳蛋白,赋予PMNR乳腺肿瘤归巢特异性。本项目的总体假设是:(1)纳米棒样fd-tet噬菌体的主要外壳蛋白(pVIII),通过主要外壳噬菌体展示技术对其进行基因工程改造,使其进入乳腺肿瘤;可以在表面突出肿瘤自导肽基序的dna固定金纳米棒(aunr)上进行仿生自组装;(2)所得到的多功能PMNR将作为乳腺肿瘤靶向纳米加热器,在近红外照射下选择性破坏乳腺肿瘤。我们设计了三个特定的目标来验证我们的中心假设:目标1:从噬菌体展示的随机肽库中鉴定融合到纳米棒样噬菌体pVIII的肿瘤归家肽。目的2:通过模拟天然噬菌体组装过程中pVIII沿着DNA组装的过程,在DNA固定的aunr上建立肿瘤归家噬菌体蛋白的仿生组装,形成肿瘤归家pmnr。目的3:利用肿瘤靶向pmnr检测乳腺肿瘤光热消融。该项目将产生一种新的肿瘤归巢抗癌药物和乳腺癌靶向治疗的新策略。它还将产生一种新的仿生策略,用于赋予纳米医学中纳米材料的生物识别。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Chuanbin Mao其他文献
Chuanbin Mao的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Chuanbin Mao', 18)}}的其他基金
Virus-based nanoparticles for detecting breast cancer biomarkers
基于病毒的纳米粒子用于检测乳腺癌生物标志物
- 批准号:
9265843 - 财政年份:2016
- 资助金额:
$ 21.27万 - 项目类别:
Hiring Non-toxic Virus Nanoparticles to Count Cancer Biomarker Molecules
使用无毒病毒纳米颗粒来计数癌症生物标志物分子
- 批准号:
9070724 - 财政年份:2015
- 资助金额:
$ 21.27万 - 项目类别:
Hiring Non-toxic Virus Nanoparticles to Count Cancer Biomarker Molecules
使用无毒病毒纳米颗粒来计数癌症生物标志物分子
- 批准号:
8873755 - 财政年份:2015
- 资助金额:
$ 21.27万 - 项目类别:
Selective tumor inhibition by tumor-homing angiogenesis-suppressing nanofibers
通过肿瘤归巢血管生成抑制纳米纤维选择性抑制肿瘤
- 批准号:
9110918 - 财政年份:2015
- 资助金额:
$ 21.27万 - 项目类别:
Tubulin-Binding Upconversion Nanoparticles for Breast-Cancer Imaging and Therapy
用于乳腺癌成像和治疗的微管蛋白结合上转换纳米颗粒
- 批准号:
8386466 - 财政年份:2012
- 资助金额:
$ 21.27万 - 项目类别:
Tubulin-Binding Upconversion Nanoparticles for Breast-Cancer Imaging and Therapy
用于乳腺癌成像和治疗的微管蛋白结合上转换纳米颗粒
- 批准号:
8507732 - 财政年份:2012
- 资助金额:
$ 21.27万 - 项目类别:
Bone-seeking and cell-targeting non-viral vectors for BMP-2 gene delivery
用于 BMP-2 基因传递的骨寻找和细胞靶向非病毒载体
- 批准号:
8136845 - 财政年份:2011
- 资助金额:
$ 21.27万 - 项目类别:
Bone-seeking and cell-targeting non-viral vectors for BMP-2 gene delivery
用于 BMP-2 基因传递的骨寻找和细胞靶向非病毒载体
- 批准号:
7895826 - 财政年份:2009
- 资助金额:
$ 21.27万 - 项目类别:
Phage-inspired nanoparticles with genetically tunable target-specificity
具有基因可调靶点特异性的噬菌体纳米颗粒
- 批准号:
7942938 - 财政年份:2009
- 资助金额:
$ 21.27万 - 项目类别:
Phage-inspired nanoparticles with genetically tunable target-specificity
具有基因可调靶点特异性的噬菌体纳米颗粒
- 批准号:
7737268 - 财政年份:2009
- 资助金额:
$ 21.27万 - 项目类别:
相似海外基金
Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
- 批准号:
23H01982 - 财政年份:2023
- 资助金额:
$ 21.27万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
- 批准号:
23KJ0116 - 财政年份:2023
- 资助金额:
$ 21.27万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
- 批准号:
10682794 - 财政年份:2023
- 资助金额:
$ 21.27万 - 项目类别:
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
- 批准号:
10598276 - 财政年份:2023
- 资助金额:
$ 21.27万 - 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233343 - 财政年份:2023
- 资助金额:
$ 21.27万 - 项目类别:
Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233342 - 财政年份:2023
- 资助金额:
$ 21.27万 - 项目类别:
Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
- 批准号:
479363 - 财政年份:2023
- 资助金额:
$ 21.27万 - 项目类别:
Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
- 批准号:
10681989 - 财政年份:2023
- 资助金额:
$ 21.27万 - 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
- 批准号:
2237240 - 财政年份:2023
- 资助金额:
$ 21.27万 - 项目类别:
Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
- 批准号:
2305592 - 财政年份:2023
- 资助金额:
$ 21.27万 - 项目类别:
Continuing Grant